TechBio Founders #16:  Accelerating drug discovery with fully automated robotic  experiment execution and digital data capture with Martin-Immanuel Bittner, CEO Arctoris episode artwork

EPISODE · May 5, 2023 · 41 MIN

TechBio Founders #16: Accelerating drug discovery with fully automated robotic experiment execution and digital data capture with Martin-Immanuel Bittner, CEO Arctoris

from Next Sequence · host Martin-Immanuel Bittner, Loretta TIOIELA

Arctoris is a tech-enabled drug discovery company headquartered in Oxford and Boston. Arctoris combines its unique automation platform, Ulysses, with advanced computational approaches and a world-class team of seasoned drug hunters to guide and rapidly progress its wholly owned and partnered drug discovery programs in oncology and neurology.

NOW PLAYING

TechBio Founders #16: Accelerating drug discovery with fully automated robotic experiment execution and digital data capture with Martin-Immanuel Bittner, CEO Arctoris

0:00 41:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Next Sequence?

This episode is 41 minutes long.

When was this Next Sequence episode published?

This episode was published on May 5, 2023.

What is this episode about?

Arctoris is a tech-enabled drug discovery company headquartered in Oxford and Boston. Arctoris combines its unique automation platform, Ulysses, with advanced computational approaches and a world-class team of seasoned drug hunters to guide and...

Can I download this Next Sequence episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!